Thermo Fisher的股权有所上升,尽管内幕销售量很大,但后者的收益仍然很高。 Shorepoint Capital and others boosted stakes in Thermo Fisher, which reported strong earnings, despite insider sales.

Shorepoint资本伙伴公司和其他投资公司增加了对提供科学和诊断产品的Thermo Fisher Science公司的股份。 Shorepoint Capital Partners and other investment firms increased their stakes in Thermo Fisher Scientific, a company that provides scientific and diagnostic products. Thermo Fisher报告,根据分析家预测,每股5.15美元的丰收和10.36亿美元的收入。 Thermo Fisher reported strong earnings of $5.15 per share and revenue of $10.36 billion, beating analyst predictions. 然而,公司内部人士最近出售了大量股份。 However, company insiders have sold a significant amount of shares recently. 该股票的市场上限为1600亿美元,P/E比率为25.65。 The stock has a market cap of $160 billion and a P/E ratio of 25.65.